SubHero Banner

Comirnaty® and Spikevax® (Omicron XBB.1.5) vaccines – FDA approval and Emergency Use Authorization

September 11, 2023 - The FDA approved Pfizer/BioNTech’s Comirnaty (Omicron XBB.1.5) and Moderna’s Spikevax (Omicron XBB.1.5) COVID-19 vaccines in individuals 12 years of age and older as a single dose at least 2 months since the last dose of any COVID-19 vaccine.

Download PDF